3.06

4.97% -0.16

After Hours: 3.05 -0.01 -0.33%

Evotec Se Adr (EVO)

Overview News Price History Why EVO Down? Discussions Forecast Stock Split Dividend History

Evotec Se Adr stock is traded at $3.06, with a volume of 75,427. It is down -4.97% in the last 24 hours and down -21.94% over the past month. Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Previous Close:

$3.22

Open:

$3.09

24h Volume:

75,427

Relative Volume:

1.06

Market Cap:

$1.09B

Revenue:

$842.96M

Net Income/Loss:

$-185.63M

P/E Ratio:

-5.8186

EPS:

-0.5259

Net Cash Flow:

$-228.52M

1W Performance:

-7.55%

1M Performance:

-21.94%

6M Performance:

-10.79%

1Y Performance:

-59.25%

1-Day Range:

$3.00

$3.1292

1-Week Range:

$3.00

$3.37

52-Week Range:

$2.85

$7.98

Evotec Se Adr Stock (EVO) Company Profile

Name

Evotec Se Adr

Sector

Healthcare (1162)

Industry

Drug Manufacturers - Specialty & Generic (1)

Phone

Address

Employee

5,022

Twitter

Next Earnings Date

2024-11-06

Latest SEC Filings

EVO's Discussions on Twitter

Compare EVO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
EVO Evotec Se Adr	3.06	1.09B	842.96M	-185.63M	-228.52M	-0.5259
ZTS Zoetis Inc	151.73	67.94B	9.26B	2.49B	2.30B	5.47
TAK Takeda Pharmaceutical Co Adr	14.72	46.50B	30.25B	1.37B	5.08B	0.4257
HLN Haleon Plc Adr	9.89	44.66B	14.35B	1.85B	0	0.4023
TEVA Teva Pharmaceutical Industries Ltd Adr	13.80	15.81B	16.54B	-1.64B	749.00M	-1.45
UTHR United Therapeutics Corp	292.46	13.14B	2.76B	1.11B	898.10M	22.77

Evotec Se Adr Stock (EVO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-07-24	Downgrade	Jefferies	Buy → Hold
Aug-08-24	Downgrade	Deutsche Bank	Hold → Sell
Jul-29-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jul-11-24	Downgrade	Deutsche Bank	Buy → Hold
Apr-12-24	Upgrade	Deutsche Bank	Hold → Buy
Jan-18-24	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Jun-23-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jun-16-23	Downgrade	BofA Securities	Buy → Neutral
Jun-08-23	Upgrade	Citigroup	Neutral → Buy
Apr-04-23	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Dec-09-22	Initiated	H.C. Wainwright	Buy
Nov-16-22	Downgrade	Deutsche Bank	Buy → Hold
Aug-10-22	Downgrade	Morgan Stanley	Overweight → Underweight
Mar-02-22	Resumed	Cowen	Outperform
Jan-07-22	Resumed	Citigroup	Neutral